Top Markets
Coin of the day
Original BioMedicals Co., Ltd. Original BioMedicals Co., Ltd.

Original BioMedicals Co., Ltd.

6483
Rank in Stocks #27940
Original BioMedicals Co., Ltd. is a biotechnology company focused on creating... Original BioMedicals Co., Ltd. is a biotechnology company focused on creating novel chemical compounds to fulfill critical medical requirements, with an initial emphasis on the healthcare landscape in Taiwan. Its current product pipeline encompasses several key developments: Radprotect (A01): A pre-clinical stage compound designed to offer protection against radiation exposure. CCM-Ami (A02): Engineered to shield healthy tissues from the damaging side effects of both chemotherapy drugs and ionizing radiation. GLP-1 CCM (P01): A therapeutic agent developed for the management of type 2 diabetes. The firm was established in 2011 and operates from its base in Taipei, Taiwan.
Share Price
$0.44359644
Market Cap
$29.64M
Change (1 day)
-0.36%
Change (1 year)
-3.66%
Country
TW
Trade Original BioMedicals Co., Ltd. (6483)

Category

P/B ratio for Original BioMedicals Co., Ltd. (6483)
P/B ratio as of 2026 TTM: 0
According to Original BioMedicals Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Original BioMedicals Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors